Remote Monitoring Software for Heart Failure Patients With Implanted Heart Devices
Tests SmartSignalHF remote monitoring in adults with heart failure and implanted devices.
Plain-language title generated from the registry record
Registry title: Heart Failure Management for Patient With CIED Remotely Monitored
Key facts
- Where
- Paris, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07247032, who can take part
Where in France
- ImplicityParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Implicity
- Trial code
- NCT07247032
- Record updated
- 31 March 2026
- Original description
This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote monitoring (RM) standard of care in implanted patients with heart failure. The primary objective is to determine whether SmartSignalHF reduces all-cause mortality and HF hospitalizations at 12 months.Read full original descriptionShow less
Prospective Real World Heart Failure Management for Patient With CIED Remotely Monitored
This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote monitoring (RM) standard of care in implanted patients with heart failure. The primary objective is to determine whether SmartSignalHF reduces all-cause mortality and HF hospitalizations at 12 months.
Inclusion: Patient aged 18-85; Patient diagnosed with a New York Heart Association (NYHA) class II or III; Patients with left ventricular ejection fraction ≼ 40 %; Patient implanted with an ICD or CRT-D (BiV and/or LBBA pacing) since at least 30 days and compatible with SignalHF (Biotronik, Boston Scientific and Medtronic); Non-activation of others HF multisensor algorithms; Patient remote monitored on Implicity CIED platform; Patient with a documented diagnosis of heart failure, eligible to reimbursement in France or Germany for HF remote monitoring; Patient is willing to be remotely monitored for heart failure; HF treated according to European Society of Cardiology (ESC) guidelines.
Exclusion: Patients enrolled in concurrent clinical studies; Patients already receiving remote monitoring for heart failure; Patients undergoing or awaiting heart transplant or left ventricular assist device (LVAD) procedures; Patients with a history of non-compliance with medical care or inability to comply with the study protocol; Patients with a life expectancy of less than 12 months; Pregnant or breastfeeding women; Subjects under legal protection.